Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
With 43.2% CAGR, Global CAR-T Cell Therapy Market Size Envisaged to reach USD 118,680.68 Million By 2032: Polaris Market Research | ||||||||||||||||||||
By: PR Newswire Association LLC. - 29 May 2023 | Back to overview list |
|||||||||||||||||||
NEW YORK, May 29, 2023 /PRNewswire/ -- A latest research report [115+] pages with 360-Degree visibility, titled "CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Target Antigen (CD19/CD22, BCMA, and Others); By Indication; By Region; Segment Forecast, 2023 - 2032" published by Polaris Market Research in its research repository. "According to research report, the global car-t cell therapy market size/share was valued at USD 3,010.24 Million in 2022 and is expected to touch USD 118,680.68 Million By 2032, growing at a CAGR of 43.2% during the forecast period." What is CAR-T Cell Therapy? How Big is CAR-T Cell Therapy Market Size?
CAR-T cell therapy, known as Chimeric antigen receptor, is a ground-breaking new component in cancer treatment. It treats specific cancers by turning your T-cells into more effective cancer-fighting machines. This treatment has shown considerable promise in curing some types of blood cancers by using your own immune cells to combat cancer, resulting in increased demand for the CAR-T cell therapy market. With CAR-T cell treatment, immune cells named T cells are taken out of the blood and given a new gene that makes them capable of identifying cancer. The T cells are injected back into the circulation once the gene has been added, where they multiply and start a range of immunological reactions meant to kill the cancer cells. It treats particular types of cancer like pediatric leukemia, lymphoma, and adult leukemia. Request Sample Copy of CAR-T Cell Therapy Market Research Report @ https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/request-for-sample (The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, Table of Contents, Graphical introduction of regional analysis, Top players in the market with their revenue analysis and our research methodology.) Our Sample Report May Includes:
Some of the Top Market Players Are:
For Additional Information on Key Players, Request to Download Sample Pages Here: https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/request-for-sample Key Growth Driving Factors
Request for a Discount on this Report Before Purchase @ https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/request-for-discount-pricing Recent Trends Influencing the Market
Segmental Analysis
CD19/CD22 dominates the Car-T cell therapy market share. Impressive clinical results have been seen with CD19-targeted CAR-T therapy when treating specific forms of lymphoma and leukemia. They have received regulatory approval and have proven effective in causing patient remission. The market dynamics are evolving, and the development of BCMA-targeted CAR-T treatments for multiple myeloma has attracted much interest. Myeloma cells strongly express BCMA, which makes it a desirable target for CAR-T cell treatment. BCMA-targeted CAR-T treatments have demonstrated excellent response rates and long-lasting remissions in patients with relapsed or refractory multiple myeloma in early clinical trials, which have yielded encouraging findings.
DLBCL is one of the most prevalent types of non-Hodgkin lymphoma and is characterized by rapidly growing tumors of B-cell origin. It is a significant indication in the CAR-T cell therapy market and holds a considerable market share. The use of CAR-T cell therapy in treating DLBCL has delivered encouraging results. CAR-T therapy improves the immune system's capacity to identify and destroy cancer cells by genetically altering a patient's own T cells to express CARs that target particular proteins in cancer cells. Inquire more about this report before purchase @ https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market/inquire-before-buying (Inquire a report quote OR available discount offers to the sales team before purchase.) CAR-T Cell Therapy Market: Report Scope
Geographical Overview
Browse the Detail Report "CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Target Antigen (CD19/CD22, BCMA, and Others); By Indication; By Region; Segment Forecast, 2023 - 2032" with in-depth TOC: https://www.polarismarketresearch.com/industry-analysis/car-t-cell-therapy-market For Additional Information OR Media Enquiry, Please Mail At: sales@polarismarketresearch.com Recent Developments
Key Questions Answered in The Report
Polaris Market Research has segmented the CAR-T Cell Therapy market report based on target antigen, indication, and region: By Target Antigen Outlook
By Indication Outlook
By Region Outlook
Browse More Research Reports:
About Polaris Market Research: Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers. Contact: Likhil G Logo: https://mma.prnewswire.com/media/1316207/Polaris_Market_Research_Logo.jp
View original content:https://www.prnewswire.com/news-releases/with-43-2-cagr-global-car-t-cell-therapy-market-size-envisaged-to-reach-usd-118-680-68-million-by-2032-polaris-market-research-301836592.html SOURCE Polaris Market Research |
||||||||||||||||||||
|
||||||||||||||||||||
Copyright 2023 PR Newswire Association LLC. | Back to overview list |